BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.205
+0.005 (0.12%)
Apr 25, 2025, 4:00 PM EDT - Market closed
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $151.65 million as of April 25, 2025.
Market Cap
151.65M
Enterprise Value
-194.00M
1-Year Change
n/a
Ranking
Category
Stock Price
4.21
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $151.65M, a decrease of -75.34%. That is a compound annual growth rate of -91.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 151.65M | -26.94% |
| Dec 31, 2024 | 207.56M | -66.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 208.99B |